Sinofn Health
Sinofn Health
In the rapidly evolving landscape of health and wellness, Nahrungsergänzungsmittel Flüssig (Liquid Supplements) have emerged as the gold standard for bioavailability and consumer compliance. SINOFN Health stands at the forefront of this shift, bridging the gap between cutting-edge R&D and large-scale industrial execution.
Modern procurement demands more than just low costs; it requires supply chain resilience. SINOFN operates under the "Factory 4.0" paradigm, integrating IoT-driven production lines, AI-assisted quality control, and blockchain-enabled batch tracking. This ensures that every drop of our liquid solutions meets international safety standards (ISO 22000, FSSC 22000), effectively de-risking global brands' expansion plans.
Today’s global brands face the "trust deficit" in the supplement market. By leveraging SINOFN's partnership with the Chinese Academy of Sciences, our clients gain immediate access to proprietary bioactive compounds and clinically validated delivery systems. Whether you are in the EU, North America, or emerging markets, our expertise in regulatory alignment ensures your product enters the market faster and with greater scientific credibility.
Nutrition is not one-size-fits-all. Our R&D team in Tianjin focuses on customizing formulations for specific demographics:
Led by Dr. Tan Shengjie (Peking University), focusing on metabolic disorder formulations and advanced bioavailability technology.
Dr. Zhang Ying (CAS Postdoc) drives our research into bioactive delivery systems, ensuring each product is backed by empirical data.
Hans van Dijk, our EU regulatory expert, bridges the gap between Asian manufacturing precision and Western market compliance.
A: We utilize advanced stabilization technology validated in our Tianjin R&D center. Each formula undergoes rigorous shelf-life stability testing in climate chambers to mimic various global shipping conditions, ensuring potency remains constant until the end user.
A: Yes. We offer scalable MOQ solutions. Our flexible production lines allow for pilot-scale prototyping for startups, while our high-capacity lines support enterprise-level demand without sacrificing quality.
A: This partnership grants us access to cutting-edge research, unique raw material sourcing, and specialized clinical validation methodologies that standard contract manufacturers simply cannot replicate.
